Trials / Completed
CompletedNCT00301262
Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied
A Multi-Center, Parallel Group, Flexible Dose Trial With A Double-Blind, Randomized, Placebo-Controlled Phase Followed By An Open-Label Phase To Assess The Impact Of Viagra On The Sexual Satisfaction Of Men With Mild Erectile Dysfunction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 183 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Men's quality of life (QoL) is potentially affected by mild erectile dysfunction (ED) to the same extent as it is by moderate and severe ED. This study will provide controlled clinical data measuring efficacy, QoL parameters and satisfaction changes in men with mild ED treated with Viagra versus those treated with a placebo. With an open-label extension, this study will also provide all study subjects the opportunity to receive the active drug treatment for 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Viagra (Sildenafil citrate) |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2007-09-01
- Completion
- 2007-09-01
- First posted
- 2006-03-10
- Last updated
- 2021-02-01
- Results posted
- 2008-12-09
Locations
26 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00301262. Inclusion in this directory is not an endorsement.